| PDL BioPharma: A Genentech/Roche Buyout Candidate? CVTrader submits:PDL BioPharma (PDLI) is a very unique biotech company owns a portfolio of valuable patents that bring in royalties from licensed products. Genentech/Roche (RHHBY.PK) currently has 4 marketed drugs licensing PDLI's technology: Herceptin, Avastin, Lucentis and Xolair. PDLI collects royalties from the total world-wide sales of these successful drugs at rates ranging from 1% to 3%. PDLI has several ways to enhance shareholder value; paying sizable “special” dividends, seeking new licenses or outright sell of the company. I personally think the last option may be the best for current shareholders, and there is a chance Genentech/Roche may pick this firm up. Here is my analysis why Genentech/Roche should do that.Complete Story » seekingalpha.com |
Nature Made® GreatMind - Video NATURE MADE GreatMind Brain Game Challenge Launched To Educate Adults About Cognitive Health feedproxy.google.com |
Genzyme Ekes Out Profit, Gives Weak View Genzyme posted a $23,000 profit in the second quarter after production problems hit its two biggest-selling drugs. online.wsj.com |
Good Signs Abound for Forest's New Antibiotic EP Vantage submits:Forest Laboratories’ (FRX) ceftaroline received a surprisingly unanimous backing Tuesday from an FDA advisory committee, boding well for final approval from the FDA. The relatively smooth passage also suggests that concerns that the antibiotic might be tripped up by the ongoing debate around the evaluation of such products in the US were overstated. As such, after a pretty torrid time for antibiotic approvals in the US, other companies approaching the FDA with late stage antibiotics could well be taking comfort from ceftaroline’s progress so far.Complete Story » seekingalpha.com |
PPD Opens Office in Novosibirsk, Russia [Business Wire] - PPD, Inc. today announced it has opened an office in Novosibirsk, Russia, building on the growth of its Phase II-IV clinical development services in Eastern Europe. PPD will provide clinical monitoring services in key therapeutic areas from this location. us.rd.yahoo.com |